ERJ staff report (DS)
United States - The ongoing dispute between bio-engineering companies Gevo and Butamax over bio-sourced isobutanol continues. Each company has sued the other over alleged patent infringements. At stake is the intellectual property over commercially-viable production of isobutanol by micro-organisms. The isobutanol can be used as a fuel, or as intermediates for butadiene and other molecules.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Press release from Butamax
Press release from Gevo